Company description

BNC KOREA researches and develops strategic application products that will lead the next generation bio markets for medical devices, pharmaceuticals, and cosmeceutical products containing physiologically active substances by processing hyaluronic acid and collagen, which are biomaterials. BNC KOREA, INC is the first Korean bio-venture to develop hyaluronic acid filer as a patented technology, we are focused on Hyaluronicacid/Collagen Medical Biomaterial business and Cosmeceuticals business with steady R&D and GMP facility. Also, we have an active ODM/OEM business by providing the best quality in the bio-material sector. BNC KOREA, INC has been researching technologies that can be applied in the human body by using various bio-friendly polymers and the field of research has been widening forward to the pharmaceutical industries. BNC KOREA, INC is constructing a GMP pharmaceutical facility and will finish it in early of 2020 in order to accelerate APIs businesses, and pharmaceutical businesses following development of Botulinum toxoid.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Custom Manufacturing (general category) |Vial/ Syringe Filling |Biopharmaceuticals More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90D75 See our Exhibitor Profile   See full Exhibitor List

Contact information




View all contact information